Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |